Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2011
09/29/2011US20110236421 Flavivirus host range mutations and uses thereof
09/29/2011US20110236410 Klebsiella antigens
09/29/2011US20110236407 Vaccine for runting-stunting syndrome
09/29/2011US20110236396 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
09/29/2011US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor
09/29/2011US20110236390 IL-17A Antagonists
09/29/2011US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof
09/29/2011US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
09/29/2011US20110236380 Ligands that bind il-13
09/29/2011US20110236378 Non-human mammals for the production of chimeric antibodies
09/29/2011US20110236375 Antibody variants with enhanced complement activity
09/29/2011US20110236374 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
09/29/2011US20110236370 Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes
09/29/2011US20110236366 Production and uses of type i ribosome inactivating proteins
09/29/2011US20110236338 Perhydrolase providing improved specific activity
09/29/2011US20110236337 Perhydrolase providing improved specific activity
09/29/2011US20110236336 Perhydrolase providing improved specific activity
09/29/2011US20110236335 Perhydrolase providing improved specific activity
09/29/2011US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers
09/29/2011US20110236309 Antagonists of ligands and uses thereof
09/29/2011US20110236306 Compositions and methods for the removal of biofilms
09/29/2011CA2794485A1 Methods for enhancing nucleic acid hybridization
09/29/2011CA2794187A1 Rna interference in ocular indications
09/29/2011CA2794142A1 Materials and methods related to modulation of mismatch repair and genomic stability by mir-155
09/29/2011CA2793906A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene
09/29/2011CA2793877A1 Mutations associated with cystic fibrosis
09/28/2011EP2368988A1 Modulation of Glucocorticoid Receptor Expression
09/28/2011EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
09/28/2011EP2368897A1 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
09/28/2011EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides
09/28/2011EP2367959A1 Methods and reagents for shortening incubation times in hybridization assays
09/28/2011EP2367838A1 A split dna enzyme for visual single nucleotide polymorphism typing
09/28/2011EP2367837A2 1'-substituted ribose 5'-polyphosphate analogs and their use as modulators of p2y receptor activity
09/28/2011EP1708751B1 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
09/28/2011EP1649041B1 Multimeric oxidoreductases
09/28/2011EP1633865B1 New biological entities and the use thereof
09/28/2011EP1576094B1 Methods of creating modified promoters resulting in varying levels of gene expression
09/28/2011EP1479762B1 Novel dehydrogenase and gene encoding the same
09/28/2011EP1463531B1 Methods for inhibiting ocular processes
09/28/2011EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO
09/28/2011CN1905899B EphA2 agonistic monoclonal antibodies and methods of use thereof
09/28/2011CN102202496A Resistance genes
09/28/2011CN101787364B Method for extracting DNA from old formalin-fixed tissues
09/28/2011CN101575596B Method for extracting mitochondria DNA of bull sperm
09/27/2011US8026412 Soybean MTH1 promoter and its use in constitutive expression of transgenic genes in plants
09/27/2011US8026355 Oligomeric compounds for the modulation of survivin expression
09/27/2011US8026354 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
09/27/2011US8026353 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
09/27/2011US8026352 Methods for determining the presence or absence of elite event RF-BN1 in Brassica plant material
09/27/2011US8026351 Monocyte-derived nucleic acids and related compositions and methods
09/27/2011US8026350 Tumor suppressor gene, p28ING5
09/27/2011US8026349 Polynucleotide synthesis labeling chemistry
09/27/2011US8026348 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof
09/27/2011US8026341 Transfection complexes
09/27/2011US8026225 Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapy
09/27/2011US8026223 Treating malignant tumors with high field strength electroporation of plasmids encoding IL-12
09/27/2011US8026092 Replication competent hepatitis C virus and methods of use
09/27/2011US8026090 Modified chondroitin synthase polypeptide and crystal thereof
09/27/2011US8026088 Angiogenic tyrosyl tRNA synthetase compositions and methods
09/27/2011US8026085 Methods and systems for selective fluorination of organic molecules
09/27/2011US8026072 Method of identifying compounds that bind BAFF-R
09/27/2011US8026067 Marker for prenatal diagnosis and monitoring
09/27/2011US8026064 Compositions, methods and systems for inferring bovine breed
09/27/2011US8026061 Probe, probe set, probe carrier, and testing method
09/27/2011US8026056 Compositions and methods for detecting Borrelia afzelii
09/27/2011US8026051 Peptide nucleic acid probe for detection of yeast
09/27/2011US8026050 Methods for modifying an oligonucleotide
09/27/2011US8025886 Modified VEGF-A with improved angiogenic properties
09/27/2011US8025884 Lawsonia intracellularis subunit vaccines
09/27/2011CA2475448C Method for accessing microbial diversity
09/27/2011CA2425112C Massive parallel method for decoding dna and rna
09/22/2011WO2011116313A1 Methods, kits and compositions for detection of mrsa
09/22/2011WO2011116107A2 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
09/22/2011WO2011115996A1 Method of producing transcripts using cryptic splice sites
09/22/2011WO2011115840A2 Parasite detection via endosymbiont detection
09/22/2011WO2011115818A1 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
09/22/2011WO2011113138A1 Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization
09/22/2011WO2011091389A3 Cyclovirus and method of use
09/22/2011WO2011091332A3 Novel centromeres and methods of using the same
09/22/2011US20110231963 Modified bacillus thuringiensis cry14 proteins for nematode control
09/22/2011US20110231961 Metabolic regulators
09/22/2011US20110231960 Bacterial toxin vaccine
09/22/2011US20110231959 Annotated plant genes
09/22/2011US20110231957 Method for promotion of branch formation, dwarfing, sterility, and promotion of multiple flower bud formation of plant
09/22/2011US20110231955 EFFICIENT GENE SILENCING IN PLANTS USING SHORT dsRNA SEQUENCES
09/22/2011US20110231952 Soybean nodulation factor receptor proteins, encoding nucleic acids and uses therefor
09/22/2011US20110231946 Engineering of bolting resistance in sugar beet by means of the transgenic expression of the beet homologue of flowering time control gene ft
09/22/2011US20110231942 Tiki1 and tiki2, wnt inhibitors
09/22/2011US20110230682 Microorganisms with inactivated lactate dehydrogenase gene (ldh) for chemical production
09/22/2011US20110230653 Stabilization of nucleic acids on solid supports
09/22/2011US20110230547 Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders
09/22/2011US20110230546 dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION
09/22/2011US20110230545 Eml4-alk fusion gene
09/22/2011US20110230544 Modulation of c-reactive protein expression
09/22/2011US20110230543 Oligoribonucleotide inhibitors of nrf2 and methods of use thereof for treatment of cancer
09/22/2011US20110230542 Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
09/22/2011US20110230531 Therapeutic compounds
09/22/2011US20110230421 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminus of ec-sod
09/22/2011US20110230405 Peptides and Supported Peptides for Treating Skin Diseases
09/22/2011US20110230401 Insulin fusion polypeptides